Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Rationale for a Neisseria gonorrhoeae Susceptible Only Interpretive Breakpoint for Azithromycin.

Kersh EN, Allen V, Ransom E, Schmerer M, St Cyr S, Workowski K, Weinstock H, Patel J, Ferraro MJ.

Clin Infect Dis. 2019 Apr 9. pii: ciz292. doi: 10.1093/cid/ciz292. [Epub ahead of print]

PMID:
30963175
2.

Microplate-based surface area assay for rapid phenotypic antibiotic susceptibility testing.

Flentie K, Spears BR, Chen F, Purmort NB, DaPonte K, Viveiros E, Phelan N, Krebill C, Flyer AN, Hooper DC, Smalley DL, Ferraro MJ, Vacic A, Stern E.

Sci Rep. 2019 Jan 18;9(1):237. doi: 10.1038/s41598-018-35916-0.

3.

Impact of 21st Century Cures Act on Breakpoints and Commercial Antimicrobial Susceptibility Test Systems: Progress and Pitfalls.

Humphries RM, Ferraro MJ, Hindler JA.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e00139-18. doi: 10.1128/JCM.00139-18. Print 2018 May. Review.

4.

Project Public Health Ready: History and Evolution of a Best Practice for Public Health Preparedness Planning.

Summers SK, Ferraro MJ.

Am J Public Health. 2017 Sep;107(S2):S138-S141. doi: 10.2105/AJPH.2017.303949.

5.

Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemase Production among Enterobacteriaceae.

Pierce VM, Simner PJ, Lonsway DR, Roe-Carpenter DE, Johnson JK, Brasso WB, Bobenchik AM, Lockett ZC, Charnot-Katsikas A, Ferraro MJ, Thomson RB Jr, Jenkins SG, Limbago BM, Das S.

J Clin Microbiol. 2017 Aug;55(8):2321-2333. doi: 10.1128/JCM.00193-17. Epub 2017 Apr 5.

6.

Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.

Branda JA, Strle K, Nigrovic LE, Lantos PM, Lepore TJ, Damle NS, Ferraro MJ, Steere AC.

Clin Infect Dis. 2017 Apr 15;64(8):1074-1080. doi: 10.1093/cid/cix043.

7.

Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks.

Cerqueira GC, Earl AM, Ernst CM, Grad YH, Dekker JP, Feldgarden M, Chapman SB, Reis-Cunha JL, Shea TP, Young S, Zeng Q, Delaney ML, Kim D, Peterson EM, O'Brien TF, Ferraro MJ, Hooper DC, Huang SS, Kirby JE, Onderdonk AB, Birren BW, Hung DT, Cosimi LA, Wortman JR, Murphy CI, Hanage WP.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1135-1140. doi: 10.1073/pnas.1616248114. Epub 2017 Jan 17.

8.

Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes.

Harrington SM, Buchan BW, Doern C, Fader R, Ferraro MJ, Pillai DR, Rychert J, Doyle L, Lainesse A, Karchmer T, Mortensen JE.

J Clin Microbiol. 2015 May;53(5):1639-47. doi: 10.1128/JCM.03480-14. Epub 2015 Mar 4.

9.

Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Vibrio cholerae.

Rychert J, Creely D, Mayo-Smith LM, Calderwood SB, Ivers LC, Ryan ET, Boncy J, Qadri F, Ahmed D, Ferraro MJ, Harris JB.

J Clin Microbiol. 2015 Jan;53(1):329-31. doi: 10.1128/JCM.02666-14. Epub 2014 Nov 12.

10.

Desmoid-type fibromatosis of the mesentery: report of a sporadic case with emphasis on differential diagnostic problems.

Li Destri G, Ferraro MJ, Calabrini M, Pennisi M, Magro G.

Case Rep Med. 2014;2014:850180. doi: 10.1155/2014/850180. Epub 2014 Sep 30.

11.

Elevated Staphylococcus ceftriaxone MICs are an Etest artifact.

Limbago BM, Pierce VM, Lonsway DR, Ferraro MJ.

Clin Infect Dis. 2015 Jan 1;60(1):162-3. doi: 10.1093/cid/ciu743. Epub 2014 Sep 28. No abstract available.

12.

The practice of clinical pathology: a quantitative description of laboratory director activities at a large academic medical center.

Branda JA, Dighe AS, Dzik W, Ferraro MJ, Flood J, Lee-Lewandrowski E, Makar R, Mandokolathur M, Rosenberg ES, Saidman S, Sluss P, Sohani AR, Stowell C, Van Cott EM, Lewandrowski KB.

Am J Clin Pathol. 2014 Aug;142(2):144-9. doi: 10.1309/AJCP3NU7AOPPKYWO.

PMID:
25015853
13.

Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.

Siedner MJ, Galar A, Guzmán-Suarez BB, Kubiak DW, Baghdady N, Ferraro MJ, Hooper DC, O'Brien TF, Marty FM.

Clin Infect Dis. 2014 Jun;58(11):1554-63. doi: 10.1093/cid/ciu182. Epub 2014 Mar 18.

14.

Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria.

Branda JA, Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia LF, Westblade LF, Ferraro MJ.

Diagn Microbiol Infect Dis. 2014 Feb;78(2):129-31. doi: 10.1016/j.diagmicrobio.2013.08.013. Epub 2013 Dec 8.

PMID:
24321357
15.

Better tests, better care: improved diagnostics for infectious diseases.

Caliendo AM, Gilbert DN, Ginocchio CC, Hanson KE, May L, Quinn TC, Tenover FC, Alland D, Blaschke AJ, Bonomo RA, Carroll KC, Ferraro MJ, Hirschhorn LR, Joseph WP, Karchmer T, MacIntyre AT, Reller LB, Jackson AF; Infectious Diseases Society of America (IDSA).

Clin Infect Dis. 2013 Dec;57 Suppl 3:S139-70. doi: 10.1093/cid/cit578. Review. Erratum in: Clin Infect Dis. 2014 May;58(9):1346.

16.

Reply to "risks of 'blind' automated identification systems in medical microbiology".

Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA.

J Clin Microbiol. 2013 Nov;51(11):3912. doi: 10.1128/JCM.02349-13. No abstract available.

17.

Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli.

Manji R, Bythrow M, Branda JA, Burnham CA, Ferraro MJ, Garner OB, Jennemann R, Lewinski MA, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Westblade LF, Ginocchio CC.

Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):337-46. doi: 10.1007/s10096-013-1961-2. Epub 2013 Sep 10.

PMID:
24019163
18.

Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system.

Richter SS, Sercia L, Branda JA, Burnham CA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Rychert JA, Westblade LF, Procop GW.

Eur J Clin Microbiol Infect Dis. 2013 Dec;32(12):1571-8. doi: 10.1007/s10096-013-1912-y. Epub 2013 Jul 2.

PMID:
23818163
19.

Performance of the Vitek MS v2.0 system in distinguishing Streptococcus pneumoniae from nonpneumococcal species of the Streptococcus mitis group.

Branda JA, Markham RP, Garner CD, Rychert JA, Ferraro MJ.

J Clin Microbiol. 2013 Sep;51(9):3079-82. doi: 10.1128/JCM.00824-13. Epub 2013 Jun 19.

20.

New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States.

Rasheed JK, Kitchel B, Zhu W, Anderson KF, Clark NC, Ferraro MJ, Savard P, Humphries RM, Kallen AJ, Limbago BM.

Emerg Infect Dis. 2013 Jun;19(6):870-8. doi: 10.3201/eid1906.121515.

21.

Multicenter study evaluating the Vitek MS system for identification of medically important yeasts.

Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA.

J Clin Microbiol. 2013 Jul;51(7):2267-72. doi: 10.1128/JCM.00680-13. Epub 2013 May 8.

22.

Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria.

Rychert J, Burnham CA, Bythrow M, Garner OB, Ginocchio CC, Jennemann R, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Sercia L, Westblade LF, Ferraro MJ, Branda JA.

J Clin Microbiol. 2013 Jul;51(7):2225-31. doi: 10.1128/JCM.00682-13. Epub 2013 May 8.

23.

Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.

Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC.

Clin Infect Dis. 2013 Aug;57(3):333-40. doi: 10.1093/cid/cit235. Epub 2013 Apr 16.

PMID:
23592827
24.

Primary neuroendocrine lung tumor presenting with acute ileal obstruction. Case report.

Li Destri G, Ferraro MJ, Vecchio G, Musumeci A, Calabrini M, Giarrizzo A.

G Chir. 2013 Mar;34(3):78-81.

PMID:
23578411
25.

Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.

Dudley MN, Ambrose PG, Bhavnani SM, Craig WA, Ferraro MJ, Jones RN; Antimicrobial Susceptibility Testing Subcommittee of the Clinical and Laboratory Standards Institute.

Clin Infect Dis. 2013 May;56(9):1301-9. doi: 10.1093/cid/cit017. Epub 2013 Jan 18. Review.

PMID:
23334813
26.

Growth detection failures by the nonradiometric Bactec MGIT 960 mycobacterial culture system.

Peña JA, Ferraro MJ, Hoffman CG, Branda JA.

J Clin Microbiol. 2012 Jun;50(6):2092-5. doi: 10.1128/JCM.00108-12. Epub 2012 Apr 4.

27.

Introduction: Solving the clinical problem of vancomycin resistance.

Moellering RC Jr, Ferraro MJ.

Clin Infect Dis. 2012 Apr;54 Suppl 3:S201-2. doi: 10.1093/cid/cir1046. No abstract available.

PMID:
22431849
28.

Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.

Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ.

Clin Infect Dis. 2011 Sep;53(6):541-7. doi: 10.1093/cid/cir464.

PMID:
21865190
29.

Case records of the Massachusetts General Hospital. Case 20-2011. A 30-year-old man with diarrhea after a trip to the Dominican Republic.

Ryan ET, Madoff LC, Ferraro MJ.

N Engl J Med. 2011 Jun 30;364(26):2536-41. doi: 10.1056/NEJMcpc1100928. No abstract available.

PMID:
21714651
30.

Collaborative evaluation of an erythromycin-clindamycin combination well for detection of inducible clindamycin resistance in beta-hemolytic streptococci by use of the CLSI broth microdilution method.

Jorgensen JH, McElmeel ML, Fulcher LC, McGee L, Richter SS, Heilmann KP, Ferraro MJ, Spargo J, Glennen A.

J Clin Microbiol. 2011 Aug;49(8):2884-6. doi: 10.1128/JCM.00912-11. Epub 2011 Jun 22.

31.

Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea.

Harris JB, Ivers LC, Ferraro MJ.

N Engl J Med. 2011 Jun 23;364(25):2452-61. doi: 10.1056/NEJMcpc1100927. No abstract available.

PMID:
21696312
32.

A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection.

Hyle EP, Shu B, Lindstrom S, Klimov A, Hancock K, Ferraro MJ, Traum AZ, Michelow IC.

Pediatr Transplant. 2012 Aug;16(5):E158-61. doi: 10.1111/j.1399-3046.2011.01490.x. Epub 2011 Mar 23.

PMID:
21429059
33.

Case records of the Massachusetts General Hospital. Case 2-2011. A 30-year-old woman with shock after treatment of a furuncle.

Moellering RC Jr, Abbott GF, Ferraro MJ.

N Engl J Med. 2011 Jan 20;364(3):266-75. doi: 10.1056/NEJMcpc1003886. No abstract available.

PMID:
21247318
34.

Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes.

Hyle EP, Ferraro MJ, Silver M, Lee H, Hooper DC.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1242-9. doi: 10.1086/657138. Epub 2010 Oct 28.

PMID:
21029005
35.

Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.

Klempner MS, Talbot EA, Lee SI, Zaki S, Ferraro MJ.

N Engl J Med. 2010 Aug 19;363(8):766-77. doi: 10.1056/NEJMcpc1003887. No abstract available.

PMID:
20818879
36.

Multicenter study to determine disk diffusion and broth microdilution criteria for prediction of high- and low-level mupirocin resistance in Staphylococcus aureus.

Swenson JM, Wong B, Simor AE, Thomson RB, Ferraro MJ, Hardy DJ, Hindler J, Jorgensen J, Reller LB, Traczewski M, McDougal LK, Patel JB.

J Clin Microbiol. 2010 Jul;48(7):2469-75. doi: 10.1128/JCM.00340-10. Epub 2010 May 5.

37.

2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test.

Branda JA, Aguero-Rosenfeld ME, Ferraro MJ, Johnson BJ, Wormser GP, Steere AC.

Clin Infect Dis. 2010 Jan 1;50(1):20-6. doi: 10.1086/648674.

PMID:
19947857
38.

High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides.

Lichterfeld M, Ferraro MJ, Davis BT.

Int J Antimicrob Agents. 2010 Jan;35(1):96. doi: 10.1016/j.ijantimicag.2009.08.019. Epub 2009 Nov 5. No abstract available.

PMID:
19896341
39.

Antimicrobial susceptibility testing: a review of general principles and contemporary practices.

Jorgensen JH, Ferraro MJ.

Clin Infect Dis. 2009 Dec 1;49(11):1749-55. doi: 10.1086/647952. Review.

PMID:
19857164
40.

A collagen-binding adhesin, Acb, and ten other putative MSCRAMM and pilus family proteins of Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis Group, biotype I).

Sillanpää J, Nallapareddy SR, Qin X, Singh KV, Muzny DM, Kovar CL, Nazareth LV, Gibbs RA, Ferraro MJ, Steckelberg JM, Weinstock GM, Murray BE.

J Bacteriol. 2009 Nov;191(21):6643-53. doi: 10.1128/JB.00909-09. Epub 2009 Aug 28.

41.
42.

Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp.

Swenson JM, Brasso WB, Ferraro MJ, Hardy DJ, Knapp CC, Lonsway D, McAllister S, Reller LB, Sader HS, Shortridge D, Skov R, Weinstein MP, Zimmer BL, Patel JB.

J Clin Microbiol. 2009 Jun;47(6):1902-5. doi: 10.1128/JCM.02304-08. Epub 2009 Apr 8.

43.

Adherence characteristics of endocarditis-derived Streptococcus gallolyticus ssp. gallolyticus (Streptococcus bovis biotype I) isolates to host extracellular matrix proteins.

Sillanpää J, Nallapareddy SR, Singh KV, Ferraro MJ, Murray BE.

FEMS Microbiol Lett. 2008 Dec;289(1):104-9. doi: 10.1111/j.1574-6968.2008.01378.x.

44.

Case records of the Massachusetts General Hospital. Case 34-2008. A 58-year-old woman with neck pain and fever.

Gerberding JL, Romero JM, Ferraro MJ.

N Engl J Med. 2008 Oct 30;359(18):1942-9. doi: 10.1056/NEJMcpc0806980. No abstract available.

PMID:
18971496
45.

Correction of a reference to clinical laboratory standards institute interpretive criteria.

Wikler MA, Ferraro MJ.

Clin Infect Dis. 2008 Jun 1;46(11):1798; author reply 1798-9. doi: 10.1086/588056. No abstract available.

PMID:
18462124
46.

Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells.

Swenson JM, Brasso WB, Ferraro MJ, Hardy DJ, Knapp CC, McDougal LK, Reller LB, Sader HS, Shortridge D, Skov R, Weinstein MP, Zimmer BL, Patel JB.

J Clin Microbiol. 2007 Dec;45(12):3954-7. Epub 2007 Oct 17.

47.

Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species.

Eremeeva ME, Gerns HL, Lydy SL, Goo JS, Ryan ET, Mathew SS, Ferraro MJ, Holden JM, Nicholson WL, Dasch GA, Koehler JE.

N Engl J Med. 2007 Jun 7;356(23):2381-7.

48.

Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.

Curcio D, Fernández F, Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Sader HS.

J Clin Microbiol. 2007 Jun;45(6):2095; author reply 2095-6. No abstract available.

49.

Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae.

Sader HS, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Jones RN.

J Clin Microbiol. 2007 May;45(5):1640-3. Epub 2007 Mar 14.

50.

Sensitivity of peripheral blood smear review for the diagnosis of Candida fungemia.

Branda JA, Ferraro MJ, Kratz A.

Arch Pathol Lab Med. 2007 Jan;131(1):97-101.

PMID:
17227130

Supplemental Content

Loading ...
Support Center